Evidence map›Paper›PMID 40569679›Full record

ArticleKidney3602025

Medication Mindfulness: Implementation and Evaluation of a Single-Site, 6-Month Deprescribing Intervention for Patients on Hemodialysis.

Noah Zlotnik, Angelina Abbaticchio, Madeline Theodorlis, Michelle S Cross, Abhijat Kitchlu, Jo-Anne Wilson, Anna R Gagliardi, Marisa Battistella

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney360, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Noah ZlotnikLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Angelina AbbaticchioDepartment of Pharmacy, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Madeline TheodorlisDepartment of Pharmacy, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Michelle S CrossDepartment of Pharmacy, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Abhijat KitchluDivision of Nephrology, University Health Network, Toronto, Ontario, Canada.ORCID 0000-0002-4340-5046
Jo-Anne WilsonFaculty of Health, College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.ORCID 0000-0003-3423-5740
Anna R GagliardiToronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.ORCID 0000-0002-5721-809
Marisa BattistellaLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-9456-4365

Funding

Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease KMI-181879Kidney Foundation of Canada 838159-21AHKRG
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CKDclinical nephrologyclinical trialdialysishemodialysiskidney diseasenephrology

Identifiers

PMID40569679
PMCPMC12708392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.